Petra Lutterbuese
Principal Scientist Amgen
Seminars
Thursday 9th July 2026
Preclinical Safety Assessment of Dual ‘AND’ TCEs: Challenges in Selecting Good Target Pairs
11:30 am
- Preclinical development of a dual-targeting T-cell Engager (TCE) – AMG 305
- Leveraging different techniques in a weight of evidence (WoE) approach to uncover target co-localisation in normal human tissues
- Challenges with relevant species determination for AND-gated targets
